Search
for

    Sort by

    Research 121–150 of 1000+

    1. A quantitative hair growth assessment in androgenetic alopecia after application of two cosmetic lotions versus 2% topical minoxidil Journal of The American Academy of Dermatology · 2005
    2. Sebocytes are the Key Regulators of Androgen Homeostasis in Human Skin 2001 · 196 citations
    3. Nipple Differentiation in Fetal Male Rats Treated with an Inhibitor of the Enzyme 5<i>α</i>-Reductase: Definition of a Selective Role for Dihydrotestosterone* Endocrinology · 1986 · 53 citations
    4. Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro PubMed · 2019 · 4 citations
    5. Re: Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men with Suppressed Testosterone Production: A Randomized Controlled Trial The Journal of Urology · 2012
    6. Clinical and endocrine effects of finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism Fertility and Sterility · 1995 · 70 citations
    7. Finasteride for female androgenetic alopecia British Journal of Dermatology · 2002 · 51 citations
    8. Evaluation of the 5α-reductase inhibitor finasteride on reproduction and gonadal development in medaka, Oryzias latipes General and Comparative Endocrinology · 2015 · 7 citations
    9. Expression of type 1 5α-reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthic®): a new model for screening skin-targeted androgen modulators International Journal of Cosmetic Science · 2000 · 3 citations
    10. Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study Frontiers in Pharmacology · 2026
    11. Metabolite identification by mass spectrometry of the 5α-reductase inhibitor finasteride in vitro and in vivo 2009
    12. マストミス雌雄前立腺における5α-reductase inhibitor (Finasteride)の影響 2006
    13. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005
    14. Effect of androgen on VEGF and VEGFR-2(FLK-1/KDR) expression in rat corpus cavernous Zhonghua shiyan waike zazhi · 2003
    15. Finasteride niet werkzaam bij oudere vrouwen met androgene alopecia Medisch-Farmaceutische Mededelingen · 2002
    16. The 5α-reductase inhibitor finasteride reduces opioid self-administration bioRxiv (Cold Spring Harbor Laboratory) · 2020
    17. VIBRATIONAL SPECTROSCOPIC INVESTIGATION AND MOLECULAR STRUCTURE OF A 5α-REDUCTASE INHIBITOR: FINASTERIDE Química Nova · 2020
    18. Dyslipidemia in patients with androgenetic alopecia. Statins, finasteride or both? Journal of The European Academy of Dermatology and Venereology · 2017
    19. Cosmeceutical Treatments for Androgenetic Alopecia 2015
    20. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. The Journal of Clinical Endocrinology and Metabolism · 1994 · 59 citations
    21. Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. The Journal of Clinical Endocrinology and Metabolism · 1992 · 34 citations
    22. Effective treatment of female androgenic alopecia with dutasteride. PubMed · 2005 · 33 citations
    23. A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol BMC Cancer · 2024 · 4 citations
    24. Ficus benghalensis as Potential Inhibitor of 5α-Reductase for Hair Growth Promotion: In Vitro, In Silico, and In Vivo Evaluation Frontiers in Pharmacology · 2021 · 3 citations
    25. ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW Archiv Euromedica · 2026
    26. 5 Alpha-Reductase Inhibitor Definitions · 2020
    27. Clinical trial and in vitro study investigating topical application of Zataria multiflora Boiss. and Matricaria chamomilla extracts for androgenetic alopecia Cogent Medicine · 2017
    28. Recomendaciones sobre el manejo clínico de la alopecia androgénica: un documento de consenso del Grupo Español de Tricología de la Academia Española de Dermatología y Venereología Actas Dermo-Sifiliográficas · 2024
    29. Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss Journal of The American Academy of Dermatology · 1999 · 46 citations
    30. Finasteride is the main inhibitor of 5α-reductase activity in microdissected dermal papillae of human hair follicles Archives of Dermatological Research · 1999 · 28 citations